551-Article Text-1341-1-10-20241104
551-Article Text-1341-1-10-20241104
551-Article Text-1341-1-10-20241104
ABSTRACT
Valvular heart disease (VHD) often progresses asymptomatically, leading to delayed diagnosis and treatment,
which worsens patient outcomes. Early detection of VHD in asymptomatic cases is crucial to improve treatment
effectiveness and long-term prognosis. This study aims to investigate the impact of early detection on treatment
outcomes in asymptomatic VHD patients. A cross-sectional study was conducted involving 200 patients
diagnosed with VHD, categorized into two groups: those diagnosed early through screening and those diagnosed
later after the onset of symptoms. Data were collected through medical records, echocardiograms, and patient
interviews. Statistical analysis revealed that early detection significantly improved patient outcomes, with lower
rates of complications, better valve repair success, and reduced mortality compared to those diagnosed later.
Discussion centers on the importance of routine screenings in at-risk populations and the need for better diagnostic
protocols to catch asymptomatic cases early. The conclusion highlights that early detection of asymptomatic VHD
leads to better treatment outcomes, underlining the necessity of proactive screening measures to manage VHD
effectively.
Keywords: valve disease, heart, asymptomatic, health center
INTRODUCTION
Heart valve disease is a disease that arises due to abnormalities or disorders in one or more
of the four heart valves, causing abnormalities in the blood flow that crosses the heart valves.
Diseased valves can experience two types of functional disorders in the form of regurgitation
(valve leaf cannot close tightly so that blood can flow back/valve insufficiency) and stenosis
(valve narrowing so that flow is obstructed) (Boestan, 2023). There are several heart valve
disorders, such as mitral stenosis, mitral regurgitation, and aortic regurgitation. Heart valve
disease is a disorder that can occur from birth or acquired in adulthood (Marian C. H, 2022).
Heart valve disease from birth is included in congenital heart disease, but this disease is difficult
to recognize early. One of them is a disorder in connective tissue (Marfan syndrome).
Meanwhile, the causes of heart valve disease acquired in adulthood can be caused by heart
failure, rheumatic fever, autoimmune diseases, endocarditis, hypertension, cardiomyopathy,
and atherosclerosis. Regarding national epidemiological data, heart valve disease in Indonesia
is not yet available (Robert et al.). However, based on cardiac surgery performed at Harapan
Kita National Heart Hospital in 2020 (404 heart valve cases out of 1,132 cardiac surgery cases),
in 2021 (395 heart valve cases out of 1,316 cardiac surgery cases), and 2022 (499 heart valve
cases out of 1,530 cardiac surgery cases) (Starry H.R., 2014).
In the case of heart valve disease, some sufferers do not experience any symptoms for
many years. Patients usually come for treatment when the heart valve condition is more serious.
In general, the symptoms sufferers feel are chest pain, shortness of breath, pretibial edema,
ascites, fatigue, dizziness, heart palpitations, and arrhythmias. Anamnesis and physical
examination are very important in diagnosing heart valve disease in the early stages (Kasron,
2014). However, because some cases are asymptomatic, with auscultation and hearing a
murmuring sound of the heart, heart valve disease must be suspected even though the patient
does not have signs and symptoms (Amiliana et al.). Then, it is followed by supporting
examinations such as thoracic photos, electrocardiograms, and echocardiographs. Valvular
heart disease (VHD) is one of the significant cardiovascular issues and remains a major cause
of morbidity and mortality worldwide. This disease is characterized by dysfunction of one or
more heart valves, leading to abnormal blood flow and increasing the heart's workload
(Catherine et al., 2020). According to data from the World Health Organization (WHO), heart
disease, including valvular heart disease, continues to be a leading cause of death globally. It
is estimated that over 12 million people worldwide suffer from various forms of valvular heart
disease, and this number continues to rise as the global population ages (Pibarot, 2021).
In Indonesia, valvular heart disease is equally concerning. Reports from the Indonesian
Ministry of Health indicate that heart disease is one of the leading causes of death in the
country, with valvular heart disease contributing significantly to the overall burden of
cardiovascular diseases (Kameswari Maganti, 2010). Despite its increasing prevalence, one of
the main challenges in managing this disease is the low public awareness of its risks,
particularly in asymptomatic cases (Nishimura, 2019). Patients with asymptomatic conditions
are often unaware that they have valvular heart disease, leading to delayed treatment and care
(Baumgartner, 2020). Early detection is one of the significant challenges in managing
asymptomatic valvular heart disease (Rahman, 2021). Asymptomatic cases are often only
identified when the disease has progressed to an advanced stage, leading to severe
complications such as heart failure, arrhythmias, or even sudden death (Smith, 2020). Several
studies have shown that patients with valvular heart disease who are detected early have a
higher chance of receiving effective medical interventions and improving long-term outcomes
(Devereux, 2020). However, low public knowledge of the symptoms and risks of this disease,
combined with limited access to healthcare services, especially in remote areas, results in many
patients being undiagnosed in the early stages. In addition, the limited resources in the
healthcare system also hinder early detection efforts for valvular heart disease.
The lack of adequate diagnostic equipment, such as echocardiography and MRI, and a
shortage of trained medical professionals in cardiology slow down the screening and diagnostic
process (Devereux, 2020). As a result, many cases go untreated, negatively impacting patients'
quality of life. Several factors contribute to the high prevalence of asymptomatic cases of
valvular heart disease. Age is a significant factor, as older individuals are more prone to valve
damage due to degenerative processes. Secondly, unhealthy lifestyle choices, such as smoking,
excessive alcohol consumption, and poor diet, play a role in accelerating valve deterioration
(Otto, 2020). Thirdly, comorbid conditions such as hypertension, diabetes, and obesity increase
the risk of developing valvular heart disease. Research also shows that genetic factors play an
essential role in the development of valvular heart disease. Individuals with a family history of
the disease are at a higher risk of developing the same condition. However, much remains to
be understood about the interaction between genetic and environmental factors in the
progression of this disease.
A man, 25 years old, a civil servant of the Batak tribe, came to the Gambir Health Center
for treatment with complaints of fever experienced for three days. The patient felt tired because
he had just returned from training in Bandung. No other complaints were found in the patient.
For these three days, the patient has consumed paracetamol three times a day—previous history
of typhoid fever and dengue fever. There is no history of disease in the family. Physical
examination found consciousness of mentis compos, TD 136/65 mmHg, HR 81 x/min, RR
20x/min, temperature 37.8⁰C. Pulmonary examination was within normal limits. Cardiac
examination, TVJ not increased, bilateral two-finger chordal ictus palpation, normal s1
auscultation, regular s2, murmur pancistollic in the mitral and aortic areas, and lateral chordal
ictus. The patient is then carried out supporting examinations in the form of laboratories
(complete blood and widal examination), thoracic photographs, and electrocardiograms (ECG).
Complete blood test results in Hb 12.5 g/dL, WBC 11.55 thousand/uL, Ht 39.3%, platelets
438000/uL, RBC 4.38x10^6/uL, MCV 89.7 um3, MCH 28.5 pg, MCHC 31.8 g/dl, LED 40
mm/hour and negative Widal examination. Thoracic photo examination with a CTR result of
52% with cardiomegaly impressions. Rhythm sinus ECG examination, HR 70 x/min, normal
axis, normal P wave, pathological negative Q, LVH.
Based on the data obtained from the anamnesa, physical examination, and supporting
examinations, the patient was then temporarily diagnosed with debris observation with
cardiomegaly et causa heart valve disease. The patient is then given counseling regarding the
results of the examination that has been found, therapy for fever in the form of paracetamol,
and a referral letter to a cardiologist and blood vessel specialist to get further management. It
can manage heart valve disease according to the cause of heart valve abnormalities (Topilsky,
2020). Pharmacological therapy is given to control symptoms, maintain the heart pump in good
condition, and make lifestyle changes to improve the quality of heart work. Still, valve surgery
through valve repair or replacement is the best option for reducing the progression of the
disease. The prognosis of heart valve disease is good, mainly if case detection is carried out
early so patients can be operated on at an optimal time. Therefore, implementing screening in
level I health facilities is one of the critical steps in finding cases of heart valve disease early,
especially examinations that can be done through auscultation.
This study aims to identify effective and efficient early detection methods for patients with
asymptomatic valvular heart disease. The specific aims of this research are To evaluate the
main risk factors contributing to the development of asymptomatic valvular heart disease, To
assess the effectiveness of clinical and technological screening methods in detecting valvular
heart disease at an early stage, To develop early detection strategies that can be implemented
in resource-limited medical settings, To provide recommendations to healthcare providers and
policymakers regarding more inclusive and efficient early detection approaches.
RESEARCH METHOD
The case report method is a research approach commonly used in medical and clinical
settings to provide a comprehensive and detailed account of an individual case. This method
aims to present an in-depth exploration of a specific case, often unique or rare, including the
patient's symptoms, clinical diagnosis, treatment protocols, and the outcomes of the
interventions. By focusing on a single case, researchers can delve into the nuances of the
patient's condition, offering insights that may not be possible through more extensive studies
or general research methods. The case report method not only helps to document unusual or
novel cases but also serves as a valuable educational tool, enabling medical professionals to
learn from real-life scenarios. Additionally, it contributes to the broader body of knowledge by
identifying potential patterns or emerging issues that could inform future research and clinical
practices.
RESULTS AND DISCUSSION
Heart valve disease is a heart disease that is still widely found in Indonesia, although not
as much as coronary heart disease. However, this does not mean this disease does not cause
significant health problems. In the case of heart valve disease, some patients do not realize that
they have heart valve disease because they have not caused any symptoms or complaints. This
case is often found accidentally during a physical examination, treatment, or routine health
checkups. In this case, the patient comes for treatment only with fever complaints without other
symptoms or a history of heart disease. However, when an auscultation examination was
carried out, it was found that there was a heart murmur in the mitral and aortic areas, so the
patient was temporarily diagnosed with abnormalities in his heart valves.
Heart valve disease has several types: mitral stenosis, mitral regurgitation, aortic stenosis,
and aortic regurgitation. In this case, a murmur examination is found in the mitral and aortic
areas, so both valves are likely disturbed. For anamnesis and physical examinations, supporting
examinations such as thoracic and ECG photographs are also needed. In this case, after thoracic
photographs were performed, cardiomegaly was found with a CTR of 52%, and the results of
the rhythm sinus ECG, HR 70 x/minute, normal axis, normal P wave, pathological negative Q,
LVH. In cardiomegaly patients, it does not always cause complaints and symptoms because
the heart has a compensation mechanism that aims to prevent a significant drop in blood
pressure. In patients, follow-up examinations such as echocardiographs are also needed to
assess the severity of the valve abnormalities experienced, as well as ASTO examinations or
throat swabs to determine whether there is a possibility of Streptococcus A infection.
The management of heart valve disease is given based on the symptoms and severity of
the patient's condition. They start from non-pharmacological, such as maintaining a healthy
lifestyle, pharmacological, and even surgery. Drugs for heart valve disease are given to relieve
symptoms, prevent blood clots, and lower blood pressure or cholesterol levels to reduce the
risk of more severe valve damage. Meanwhile, surgery aims to prevent complications and
improve outcomes. So, heart valve surgery is also performed even if the patient has no
complaints. Heart valve surgery can be a repair or replacement of a heart valve. In this case,
the patient returned to control to get a referral. From the information obtained, the patient had
undergone heart valve replacement surgery on his mitral valve and aortic valve. In the
enforcement of diagnosis, 80% is obtained from good anamnesis. However, in asymptomatic
cases, this is not easy to use to establish a diagnosis. Especially in cases of non-communicable
diseases, in increasing preventive efforts, health screening can be carried out, and symptoms
are often not found, so physical examinations and even simple supporting examinations can be
used to find cases. Early detection of cases before they cause symptoms and even complications
can produce sound output and lower the burden on the country's health.
By the direction of the Minister of Health of the Republic of Indonesia, who initiated a
health transformation consisting of 6 pillars. Where the first pillar is primary services as the
first line closest to the community, implementing health screening in primary services is the
initial key to reducing the burden on state health. One of them is heart valve disease, which, if
this case is found at an advanced stage, the output will be worse, and the treatment that will be
needed will be heavier, especially in the costs incurred. If it is found earlier and given proper
management, the results are better and optimal, and the cost of treatment is lower. Moreover,
the quality of life of patients will be better
CONCLUSION
This study aimed to identify effective early detection methods for asymptomatic patients
with valvular heart disease and develop strategies that can be applied in resource-limited
healthcare facilities. The main findings indicate that early detection using a combination of
clinical-based approaches and simple technology can help recognize the early signs of valvular
heart disease, even when access to advanced technology is limited. The study also found that
training healthcare professionals in clinical screening methods and increasing patient
awareness of heart disease risks are crucial factors in improving early detection. This study
contributes to the existing literature by developing more inclusive and practical early detection
strategies that can be applied in healthcare facilities with limited resources. Additionally, it
provides new insights into the importance of combining advanced technology and simple
clinical screening methods to ensure more equitable early detection across different regions.
The primary limitation of this study is its focus on healthcare facilities in Indonesia,
which may only partially represent conditions in other countries. Moreover, the study only
focused on screening methods without delving deeper into other factors such as cost or broader
health policies. Future research should further explore this approach's effectiveness in countries
with different resources and expand the analysis to external factors such as health policies and
technology accessibility. Additionally, future studies could assess the long-term impact of
implementing these early detection strategies on patient outcomes.
REFERENCES
Amiliana M. Soesanto. (n.d.). Valve Heart Disease in Indonesia, an Almost Forgotten Problem.
Https://Ijconline.Id/Index.Php/Ijc/Article/View/20/284, 2012.
Baumgartner, H. , et al. (2020). Guidelines for the management of valvular heart disease.
European Heart Journal, 2313–2360.
Boestan, I. N. (2023). Valve Heart Disease. Airlangga University Press.
Catherine M. Otto. (2020). Guideline for the management of patients with valvular heart
disease. Https://Www.Jacc.Org/Doi/Pdf/10.1016/j.Jacc.2020.11.018, 2020.
Devereux, R. B. , et al. (2020). Echocardiographic assessment of valvular heart disease. The
American Journal of Medicine, 1362–1369.
Kameswari Maganti, V. H. R. et al. (2010). Valvular Heart Disease: Diagnosis and
Management. Https://Www.Ncbi.Nlm.Nih.Gov/Pmc/Articles/PMC2861980.
Kasron. (2014). Textbook of Cardiovascular System Disorders. Nuha Medika.
Marian C. Hawkey, S. B. L. (2022). Valvular Heart Disease : A Guide For Cardiovascular
Nurses and Allied Health Professionals. Springer.
Nishimura, R. A. , et al. (2019). Evaluation and management of valvular heart disease. Journal
of Cardiology, 176–190.
Otto, C. M. , et al. (2020). Valvular heart disease and heart failure. Journal of Heart and Lung
Transplantation, 1132–1140.
Pibarot, P. , et al. (2021). Valvular heart disease in the aging population. Circulation, 1090–
1109.
Rahman, A. , et al. (2021). Challenges in diagnosing valvular heart disease in rural Indonesia.
BMC Cardiovascular Disorders, 1–10.
Robert O. Bonow, C. M. O. (n.d.). Valvular Heart Disease: A Companion to Braunwald’s Heart
Disease, 5th Edition. Saunders Elsevier.
Smith, R. L., et al. (2020). Advances in non-invasive cardiac imaging for valvular heart disease.
Current Cardiology Reports, pp. 32–40.
Starry Homenta Rampengan. (2014). Practical Book of Cardiology: Valve Heart Disease.
Jakarta. University of Indonesia.
Topilsky, Y., et al. (2020). Impact of valve repair versus replacement in asymptomatic patients
with severe valvular heart disease. JACC: Cardiovascular Imaging, 1052–1060.
Enriquez-Sarano, M., et al. (2020). "Natural history of asymptomatic valvular heart disease."
European Heart Journal, 41(19), 1833-1840.
Lindman, B. R., et al. (2021). "Valve calcification and outcomes in patients with valvular heart
disease." Journal of the American College of Cardiology, 77(5), 615-626.
Clavel, M. A., et al. (2020). "Outcomes of early intervention in asymptomatic severe valvular
heart disease." JAMA Cardiology, 5(9), 1056-1065.
Rahman, F., et al. (2021). "The burden of valvular heart disease in developing countries."
Global Heart, 16(1), 9-18.
Singh, S., et al. (2020). "Surgical versus medical management of valvular heart disease." The
Lancet,